PubRank

D A Sack

Author PubWeight™ 251.69‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Test for enterotoxigenic Escherichia coli using Y-1 adrenal cells in miniculture. Infect Immun 1975 13.58
2 Human reovirus-like agent as the major pathogen associated with "winter" gastroenteritis in hospitalized infants and young children. N Engl J Med 1976 7.57
3 Travelers' diarrhea in Mexico. A prospective study of physicians and family members attending a congress. N Engl J Med 1976 6.52
4 Special Escherichia coli serotypes among enterotoxigenic strains from diarrhoea in adults and children. Med Microbiol Immunol 1976 4.95
5 Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry 1984 4.72
6 Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up. Lancet 1990 4.62
7 Attachment of Vibrio cholerae serogroup O1 to zooplankton and phytoplankton of Bangladesh waters. Appl Environ Microbiol 1990 3.73
8 Enterotoxigenic Escherichia coli isolated from food. J Infect Dis 1977 3.52
9 Cholera control. Lancet 1994 3.38
10 Enterotoxigenic Escherichia coli and Reovirus-like agent in rural Bangladesh. Lancet 1976 3.38
11 Laboratory investigation of diarrhea in travelers to Mexico: evaluation of methods for detecting enterotoxigenic Echerichia coli. J Clin Microbiol 1976 3.34
12 Microtiter ganglioside enzyme-linked immunosorbent assay for vibrio and Escherichia coli heat-labile enterotoxins and antitoxin. J Clin Microbiol 1980 3.30
13 Diarrhoea associated with heat-stable enterotoxin-producing strains of Escherichia coli. Lancet 1975 3.27
14 Detection of Vibrio cholerae O1 in the aquatic environment by fluorescent-monoclonal antibody and culture methods. Appl Environ Microbiol 1990 3.21
15 Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine. J Infect Dis 1984 3.07
16 Prophylactic doxycycline for travelers' diarrhea. Results of a prospective double-blind study of Peace Corps volunteers in Kenya. N Engl J Med 1978 2.86
17 Field trial of oral cholera vaccines in Bangladesh. Lancet 1986 2.85
18 Epidemic diarrhea at Crater Lake from enterotoxigenic Escherichia coli. A large waterborne outbreak. Ann Intern Med 1977 2.80
19 Enterotoxigenic Escherichia-coli-associated diarrheal disease in Apache children. N Engl J Med 1975 2.74
20 Microtiter solid-phase radioimmunoassay for detection of Escherichia coli heat-labile enterotoxin. Infect Immun 1977 2.72
21 El Tor cholera with severe disease: a new threat to Asia and beyond. Epidemiol Infect 2009 2.60
22 Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial. J Infect Dis 1988 2.57
23 Plasmid-mediated resistance to nalidixic acid in Shigella dysenteriae type 1. Lancet 1987 2.32
24 Tissue-culture assay of antibodies to heat-liable Escherichia coli enterotoxins. N Engl J Med 1974 2.20
25 Intestinal antibody responses after immunisation with cholera B subunit. Lancet 1982 2.13
26 Enterotoxigenic Escherichia coli isolated from patients at a hospital in Dacca. J Infect Dis 1977 2.03
27 Enterotoxigenic Escherichia coli diarrhea of travelers: a prospective study of American Peace Corps volunteers. Johns Hopkins Med J 1977 1.88
28 Rapid diagnosis of cholera by coagglutination test using 4-h fecal enrichment cultures. J Clin Microbiol 1987 1.82
29 Oral hydration rotavirus diarrhoea: a double blind comparison of sucrose with glucose electrolyte solution. Lancet 1978 1.78
30 The O139 serogroup of Vibrio cholerae comprises diverse clones of epidemic and nonepidemic strains derived from multiple V. cholerae O1 or non-O1 progenitors. J Infect Dis 2000 1.76
31 Field trial of oral cholera vaccines in Bangladesh: results of one year of follow-up. J Infect Dis 1988 1.76
32 Antibodies to heat-labile Escherichia coli enterotoxin in Apaches in Whiteriver, Arizona. Infect Immun 1975 1.75
33 Development of oral vaccines against enterotoxinogenic Escherichia coli diarrhoea. Vaccine 1989 1.73
34 ABO blood groups and cholera: new observations on specificity of risk and modification of vaccine efficacy. J Infect Dis 1989 1.66
35 Peruvian Vibrio cholerae O1 El Tor strains possess a distinct region in the Vibrio seventh pandemic island-II that differentiates them from the prototype seventh pandemic El Tor strains. J Med Microbiol 2009 1.64
36 Local and systemic antibody responses and immunological memory in humans after immunization with cholera B subunit by different routes. Bull World Health Organ 1984 1.62
37 Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group. JAMA 1995 1.58
38 Use of monoclonal antibodies to type Shigella flexneri in Bangladesh. J Clin Microbiol 1989 1.58
39 Sleep reduction as a final common pathway in the genesis of mania. Am J Psychiatry 1987 1.55
40 One-step immunochromatographic dipstick tests for rapid detection of Vibrio cholerae O1 and O139 in stool samples. Clin Diagn Lab Immunol 2003 1.54
41 Prevalence of antibody to the Norwalk virus in various countries. Infect Immun 1979 1.54
42 Enterotoxigenic Escherichia coli diarrhoea: acquired immunity and transmission in an endemic area. Bull World Health Organ 1981 1.54
43 B subunit-whole cell and whole cell-only oral vaccines against cholera: studies on reactogenicity and immunogenicity. J Infect Dis 1987 1.47
44 Unusual association of a plasmid with nalidixic acid resistance in an epidemic strain of Shigella dysenteriae type 1 from Asia. Can J Microbiol 1991 1.40
45 Field trial of inactivated oral cholera vaccines in Bangladesh: results from 5 years of follow-up. Vaccine 1996 1.39
46 Stool electrolyte content and purging rates in diarrhea caused by rotavirus, enterotoxigenic E. coli, and V. cholerae in children. J Pediatr 1981 1.39
47 Sunlight-induced propagation of the lysogenic phage encoding cholera toxin. Infect Immun 2000 1.38
48 Prevalence of sputum smear-positive tuberculosis in a rural area in Bangladesh. Epidemiol Infect 2006 1.37
49 Rotavirus infections and climate variability in Dhaka, Bangladesh: a time-series analysis. Epidemiol Infect 2007 1.33
50 Immunobead enzyme-linked immunosorbent assay for quantitating immunoglobulin A in human secretions and serum. Infect Immun 1980 1.32
51 Altering trends in the dominance of Shigella flexneri serotypes and emergence of serologically atypical S. flexneri strains in Dhaka, Bangladesh. J Clin Microbiol 2001 1.32
52 Biotype as determinant of natural immunising effect of cholera. Lancet 1991 1.32
53 Molecular characterization of a new ribotype of Vibrio cholerae O139 Bengal associated with an outbreak of cholera in Bangladesh. J Clin Microbiol 1999 1.30
54 Field trial of oral cholera vaccines in Bangladesh: serum vibriocidal and antitoxic antibodies as markers of the risk of cholera. J Infect Dis 1991 1.29
55 Development of a novel in vitro assay (ALS assay) for evaluation of vaccine-induced antibody secretion from circulating mucosal lymphocytes. Clin Diagn Lab Immunol 2001 1.28
56 Construction and characterization of genetically defined aro omp mutants of enterotoxigenic Escherichia coli and preliminary studies of safety and immunogenicity in humans. Infect Immun 2001 1.27
57 Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients. Am J Psychiatry 1988 1.25
58 Congo red binding and salt aggregation as indicators of virulence in Shigella species. J Clin Microbiol 1988 1.24
59 Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age. Vaccine 2009 1.22
60 Reactivities of serotyping monoclonal antibodies with culture-adapted human rotaviruses. J Clin Microbiol 1991 1.22
61 Oral rehydration formula containing alanine and glucose for treatment of diarrhoea: a controlled trial. BMJ 1989 1.21
62 An oral B subunit: whole cell vaccine against cholera. Vaccine 1992 1.20
63 Evidence for natural reassortants of human rotaviruses belonging to different genogroups. J Virol 1990 1.20
64 Phototherapy of seasonal affective disorder. Time of day and suppression of melatonin are not critical for antidepressant effects. Arch Gen Psychiatry 1986 1.19
65 Role of cyanobacteria in the persistence of Vibrio cholerae O139 in saline microcosms. Can J Microbiol 2004 1.18
66 Epidemiology of rotavirus and cholera in children aged less than five years in rural Bangladesh. J Health Popul Nutr 2011 1.16
67 Increasing spectrum in antimicrobial resistance of Shigella isolates in Bangladesh: resistance to azithromycin and ceftriaxone and decreased susceptibility to ciprofloxacin. J Health Popul Nutr 2007 1.16
68 Protection of adult rabbits and monkeys from lethal shigellosis by oral immunization with a thymine-requiring and temperature-sensitive mutant of Shigella flexneri Y. Vaccine 1990 1.14
69 Acute lower respiratory tract infection due to virus among hospitalized children in Dhaka, Bangladesh. Rev Infect Dis 1991 1.13
70 Antidepressant effects of light in seasonal affective disorder. Am J Psychiatry 1985 1.13
71 Extended-spectrum beta-lactamase-mediated third-generation cephalosporin resistance in Shigella isolates in Bangladesh. J Antimicrob Chemother 2004 1.11
72 Rapid identification of Vibrio cholerae serotype O1 from primary isolation plates by a coagglutination test. J Med Microbiol 1989 1.08
73 Comparison of the antibody in lymphocyte supernatant (ALS) and ELISPOT assays for detection of mucosal immune responses to antigens of enterotoxigenic Escherichia coli in challenged and vaccinated volunteers. Vaccine 2005 1.07
74 Field trial of oral cholera vaccines in Bangladesh: evaluation of anti-bacterial and anti-toxic breast-milk immunity in response to ingestion of the vaccines. Vaccine 1990 1.06
75 Single-dose doxycycline for cholera. Antimicrob Agents Chemother 1978 1.05
76 Twenty-four-hour profiles of body temperature and plasma TSH in bipolar patients during depression and during remission and in normal control subjects. Am J Psychiatry 1988 1.04
77 Impact of B subunit killed whole-cell and killed whole-cell-only oral vaccines against cholera upon treated diarrhoeal illness and mortality in an area endemic for cholera. Lancet 1988 1.04
78 Resolution and resurgence of schistosoma haematobium-induced pathology after community-based chemotherapy in ghana, as detected by ultrasound. J Infect Dis 1999 1.04
79 Acute lower respiratory infections: a major cause of death in children in Bangladesh. Ann Trop Paediatr 1989 1.04
80 Melatonin administration in insomnia. Neuropsychopharmacology 1990 1.03
81 Breast feeding and the risk of severe cholera in rural Bangladeshi children. Am J Epidemiol 1990 1.03
82 Phototherapy for seasonal affective disorder. J Biol Rhythms 1988 1.02
83 Community-based evaluation of the effect of breast-feeding on the risk of microbiologically confirmed or clinically presumptive shigellosis in Bangladeshi children. Pediatrics 1992 1.01
84 Breastfeeding and the risk of life-threatening enterotoxigenic Escherichia coli diarrhea in Bangladeshi infants and children. Pediatrics 1997 1.00
85 The aetiology of diarrhoea in children at an urban hospital in Bangladesh. Trans R Soc Trop Med Hyg 1987 0.99
86 Cryptosporidiosis: a cause of diarrhea in Bangladesh. Am J Trop Med Hyg 1990 0.99
87 Prediction of epidemic cholera due to Vibrio cholerae O1 in children younger than 10 years using climate data in Bangladesh. Epidemiol Infect 2007 0.98
88 Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomised placebo-controlled trial. Lancet 1999 0.98
89 Glucose vs sucrose in oral rehydration solutions for infants and young children with rotavirus-associated diarrhea. Pediatrics 1981 0.97
90 Seroepidemiologic evaluation of antibodies to rotavirus as correlates of the risk of clinically significant rotavirus diarrhea in rural Bangladesh. J Infect Dis 1992 0.96
91 Solid-phase microtiter radioimmunoassay blocking test for detection of antibodies to Escherichia coli heat-labile enterotoxin. J Clin Microbiol 1979 0.96
92 The significance of enteroaggregative Escherichia coli in the etiology of hospitalized diarrhoea in Calcutta, India and the demonstration of a new honey-combed pattern of aggregative adherence. FEMS Microbiol Lett 1994 0.96
93 Acute lower respiratory tract infections in hospitalized patients with diarrhea in Dhaka, Bangladesh. Rev Infect Dis 1991 0.95
94 Diarrhea: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 2010 0.95
95 Evidence that protection against rotavirus diarrhea after natural infection is not dependent on serotype-specific neutralizing antibody. J Infect Dis 1992 0.94
96 In a randomized, double-blinded, placebo-controlled trial, the single oral dose typhoid vaccine, M01ZH09, is safe and immunogenic at doses up to 1.7 x 10(10) colony-forming units. Vaccine 2010 0.94
97 ABO blood groups and the risk of diarrhea due to enterotoxigenic Escherichia coli. J Infect Dis 1991 0.92
98 Treatment of seasonal affective disorder with light in the evening. Br J Psychiatry 1985 0.92
99 Labon-gur (common salt and brown sugar) oral rehydration solution in the treatment of diarrhoea in adults. J Trop Med Hyg 1980 0.92
100 Nonparticipation as a determinant of adverse health outcomes in a field trial of oral cholera vaccines. Am J Epidemiol 1992 0.91
101 Psychoses associated with bupropion treatment. Am J Psychiatry 1985 0.91
102 Enterotoxin-specific immunoglobulin E responses in humans after infection or vaccination with diarrhea-causing enteropathogens. Infect Immun 2000 0.91
103 Trimethoprim resistance gene in Shigella dysenteriae 1 isolates obtained from widely scattered locations of Asia. Epidemiol Infect 1990 0.91
104 The use of chlorpromazine in the treatment of cholera and other severe acute watery diarrheal diseases. Gastroenterology 1982 0.90
105 Comparison of Vibrio cholerae serotype 01 strains isolated from patients and the aquatic environment. J Trop Med Hyg 1993 0.90
106 Culture adaptation and characterization of group A rotaviruses causing diarrheal illnesses in Bangladesh from 1985 to 1986. J Clin Microbiol 1991 0.90
107 Longitudinal sleep EEG, temperature, and activity measurements across the menstrual cycle in patients with premenstrual depression and in age-matched controls. Psychiatry Res 1989 0.89
108 Which veterans go to VA psychiatric hospitals for care: a pilot study. Hosp Community Psychiatry 1985 0.89
109 Seasonal affective disorder with summer depression and winter hypomania. Am J Psychiatry 1987 0.88
110 Diminished diarrheal response to Vibrio cholerae strains carrying the replicative form of the CTX(Phi) genome instead of CTX(Phi) lysogens in adult rabbits. Infect Immun 2001 0.88
111 Zinc supplementation in the management of shigellosis in malnourished children in Bangladesh. Eur J Clin Nutr 2007 0.88
112 The effect of melatonin on normal sleep. Neuropsychopharmacology 1987 0.87
113 Low gastric acid as a risk factor for cholera transmission: application of a new non-invasive gastric acid field test. J Clin Epidemiol 1990 0.87
114 Misleading negative findings in a field trial of killed, oral cholera vaccine in Peru. J Infect Dis 2001 0.87
115 Purification of household water using a novel mixture reduces diarrhoeal disease in Matlab, Bangladesh. Trans R Soc Trop Med Hyg 2011 0.87
116 Eye versus skin phototherapy of seasonal affective disorder. Am J Psychiatry 1987 0.87
117 Pathologic study of a rabbit model for shigellosis. Lab Anim Sci 1996 0.87
118 Nutritional requirements of shigellae for growth in a minimal medium. Infect Immun 1988 0.86
119 Shiga toxin-producing Escherichia coli isolated from patients with diarrhoea in Bangladesh. J Med Microbiol 2007 0.86
120 Carbohydrate malabsorption in infants with rotavirus diarrhea. Am J Clin Nutr 1982 0.86
121 Discontinuation of breast-feeding during episodes of diarrhoea in rural Bangladeshi children. Trans R Soc Trop Med Hyg 1988 0.86
122 Sleep and circadian rhythms in affective patients isolated from external time cues. Psychiatry Res 1985 0.85
123 Environmental and behavioral influences on affective illness. Acta Psychiatr Scand Suppl 1988 0.85
124 Protection from Shigella sonnei infection by immunisation of rabbits with Plesiomonas shigelloides (SVC 01). J Med Microbiol 1992 0.85
125 Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia. Bull Pan Am Health Organ 1995 0.85
126 Seasonal affective disorder and phototherapy. Ann N Y Acad Sci 1985 0.84
127 Frequency analysis of the sleep EEG in depression. Psychiatry Res 1987 0.84
128 New cholera vaccines. Vaccine 1989 0.84
129 Highly symptom-aware children were heavily infected with urinary schistosomiasis in southern Ghana. Cent Afr J Med 2003 0.84
130 Neurobiology of seasonal affective disorder and phototherapy. J Biol Rhythms 1988 0.83
131 Risk factors for persistent diarrhoea. BMJ 1988 0.83
132 Current status of an oral B subunit whole cell cholera vaccine. Dev Biol Stand 1983 0.83
133 Agents affecting health of mother and child in a rural area of Kenya. XI. Antibodies against rotavirus in sera from children living in the Machakos District of Kenya. Trop Geogr Med 1978 0.83
134 The emerging strains of Shigella dysenteriae type 2 in Bangladesh are clonal. Epidemiol Infect 2006 0.82
135 Shigella serotypes among hospitalized patients in urban Bangladesh and their antimicrobial resistance. Epidemiol Infect 2004 0.82
136 Wastewater-grown duckweed may be safely used as fish feed. Can J Microbiol 2004 0.82
137 Atenolol in seasonal affective disorder: a test of the melatonin hypothesis. Am J Psychiatry 1988 0.82
138 Seroepidemiology of rotavirus infection in rural Bangladesh. J Clin Microbiol 1980 0.82
139 Cholera vaccine in refugee settings. JAMA 1998 0.82
140 Field trial of oral cholera vaccines in Bangladesh. Southeast Asian J Trop Med Public Health 1988 0.82
141 Randomised double blind trial of single dose doxycycline for treating cholera in adults. BMJ 1990 0.82
142 Characterization of enterotoxigenic Escherichia coli from diarrhoeal patients in Bangladesh using phenotyping and genetic profiling. J Med Microbiol 2007 0.81
143 A psychophysiological study of insomnia. Psychiatry Res 1986 0.81
144 Efficacy of a packaged rice oral rehydration solution among children with cholera and cholera-like illness. Acta Paediatr 2001 0.81
145 Neonatal diarrhea at a maternity hospital in Rangoon. Am J Public Health 1991 0.81
146 Melatonin in seasonal affective disorder and phototherapy. J Neural Transm Suppl 1986 0.80
147 Children's fluid intake during diarrhoea: a comparison of questionnaire responses with data from observations. Acta Paediatr 2002 0.80
148 Maternal cholera immunisation and scecretory IgA in breast milk. Lancet 1980 0.80
149 Nocturnal TSH and prolactin secretion during sleep deprivation and prediction of antidepressant response in patients with major depression. Biol Psychiatry 1988 0.79
150 Treatment of acute diarrhoea with oral rehydration solution. Drugs 1982 0.79
151 Evidence that inactivated oral cholera vaccines both prevent and mitigate Vibrio cholerae O1 infections in a cholera-endemic area. J Infect Dis 1992 0.79
152 Epidemiology of Aeromonas and Plesiomonas diarrhoea. J Diarrhoeal Dis Res 1988 0.79
153 Liberation of hydrogen from gastric acid following administration of oral magnesium. Dig Dis Sci 1985 0.79
154 Oral immunization against cholera. Curr Top Microbiol Immunol 1989 0.78
155 Rotavirus diarrhoea: an expanding clinical spectrum. J Trop Med Hyg 1983 0.78
156 Oral cholera vaccines containing B-subunit-killed whole cells and killed whole cells only. II. Field evaluation of cross-protection against other members of the Vibrionaceae family. Vaccine 1989 0.78
157 Seasonal affective disorder: a review of the syndrome and its public health implications. Am J Public Health 1987 0.78
158 Exclusion of clinically atypical or microbiologically mixed diarrhoeal episodes from outcome events in a field trial of oral cholera vaccines. Int J Epidemiol 1989 0.78
159 Antidepressant effects of sleep deprivation in bright and dim light. Acta Psychiatr Scand 1985 0.78
160 Neuroelectric blocking factors in human and animal sera evaluated using the isolated frog spinal cord. J Neurol Neurosurg Psychiatry 1976 0.78
161 Evaluation of conventional media for detection of colonization factor antigens of enterotoxigenic Escherichia coli. J Clin Microbiol 1993 0.77
162 Formation and selection of intergenogroup reassortants during cell culture adaptation of rotaviruses from dually infected subjects. J Virol 1991 0.77
163 Morning versus midday phototherapy of seasonal affective disorder. Am J Psychiatry 1987 0.77
164 Detection of anti-lipopolysaccharide antibodies to Vibrio cholerae O1 and O139 using a novel microtiter limulus amebocyte lysate (LAL) assay. Clin Chim Acta 2001 0.77
165 Biological effects of morning-plus-evening bright light treatment of seasonal affective disorder. Psychopharmacol Bull 1987 0.77
166 Seasonal affective disorder & light: past, present and future. Clin Neuropharmacol 1986 0.77
167 Plasma HVA and anxiety in patients with panic disorder. Biol Psychiatry 1986 0.77
168 Management of acute infectious diarrhea. Compr Ther 1980 0.76
169 Delirium induced by verapamil. Am J Psychiatry 1987 0.76
170 Chemotaxis between Vibrio cholerae O1 and a blue-green alga, Anabaena sp. Epidemiol Infect 2005 0.76
171 Oral therapy in children with cholera: a comparison of sucrose and glucose electrolyte solutions. J Pediatr 1980 0.76
172 The dexamethasone suppression test in seasonal affective disorder. Compr Psychiatry 1986 0.76
173 Neuroendocrine response to 5-hydroxytryptophan in seasonal affective disorder. Arch Gen Psychiatry 1987 0.76
174 Antidepressant effects of sleep deprivation and phototherapy. Acta Psychiatr Belg 1986 0.75
175 Combined lithium-tricyclic treatment of obsessive-compulsive disorder. Biol Psychiatry 1988 0.75
176 Optimal growth temperature for the isolation of Plesiomonas shigelloides, using various selective and differential agars. Can J Microbiol 1991 0.75
177 Enteric microbiology methods for laboratories in developing countries. Med Lab Sci 1984 0.75
178 Hyperkalaemia and glucose/electrolyte solutions. Lancet 1980 0.75
179 Oral cholera vaccines containing B-subunit-killed whole cells and killed whole cells only. I. Cross-reacting antigens of members of family Vibrionaceae and the vaccines. Vaccine 1989 0.75
180 Transition from Journal of Diarrhoeal Diseases Research to Journal of Health, Population and Nutrition. J Health Popul Nutr 2000 0.75
181 The use of phage-sensitivity patterns for tracing heat labile toxin-positive (LT+) Escherichia coli. J Med Microbiol 1989 0.75
182 Personality as a dimension of summer and winter depression. Psychopharmacol Bull 1988 0.75
183 Enteropathogenicity of plesiomonas shigelloides by oral inoculation in adult conditioned rabbits. J Diarrhoeal Dis Res 1990 0.75
184 Potentiation of antidepressant medications by phase advance of the sleep-wake cycle. Am J Psychiatry 1985 0.75
185 New and old agents in diarrhea: a prospective study of an indigenous adult African population. Am J Trop Med Hyg 1978 0.75
186 Comparison of noninvasive breath hydrogen test for gastric acid secretion to standard intubation test in infants and young children. Dig Dis Sci 1987 0.75
187 Occurrence of a large plasmid in a strain of Plesiomonas shigelloides with cross-reactivity against Shigella sonnei. Indian J Med Res 1992 0.75
188 Comparison of noninvasive breath hydrogen test for gastric acid secretion to standard intubation test in adults. Dig Dis Sci 1987 0.75
189 Risk of hypernatremia with oral rehydration. J Pediatr 1982 0.75
190 Shigellosis in Bangladesh: a reply. J Infect Dis 1987 0.75
191 Treatment of diarrhea caused by rotavirus. N Engl J Med 1981 0.75
192 Plasmid profile as a useful marker of a Shigella dysenteriae type 1 strain causing an epidemic of shigellosis. J Diarrhoeal Dis Res 1990 0.75
193 Crossed immunoelectrophoretic analysis of antigenic composition of B-subunit/whole-cell and whole-cell only killed oral cholera vaccines. Vaccine 1992 0.75
194 A novel and simple mixture as point-of-use water treatment agent to produce safe drinking water. Trans R Soc Trop Med Hyg 2014 0.75
195 Vitamin B12 deficiency and the dexamethasone suppression test. J Nerv Ment Dis 1986 0.75